| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 1,340,211 | 1,255,141 | 1,497,187 | | Cost of Revenue | 635,761 | 617,399 | 787,049 | | | Gross Profit | 704,450 | 637,742 | 710,138 | | | Operating Expenses | | Research Development | 77,914 | 88,675 | 56,641 | | Selling General and Administrative | 405,686 | 380,899 | 323,176 | | Non Recurring | 275,546 | 64,732 | 39,173 | | Others |
-
| 40,532 | 36,131 | | | | Total Operating Expenses |
-
| 574,837 | 455,121 | | | | Operating Income or Loss | (54,696) | 62,905 | 255,017 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,470) | 23,348 | 24,166 | | Earnings Before Interest And Taxes | (57,167) | 86,297 | 277,741 | | Interest Expense | 19,956 |
-
| 36,234 | | Income Before Tax | (77,123) | 86,297 | 241,506 | | Income Tax Expense | 22,620 | (30,859) | 27,070 | | Minority Interest |
-
| 263 | 80 | | | | Net Income From Continuing Ops | (99,742) | 117,419 | 214,517 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (99,742) | 117,419 | 214,517 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($99,742) | $117,419 | $214,517 |
|
1.48% Nasdaq 0.00%
Income Statement
